Impact of sucroferric oxyhydroxide on the oral and intestinal microbiome in hemodialysis patients

Hyperphosphatemia is a consequence of chronic kidney disease associated with mineral/bone impairment, increased cardiovascular events and mortality. Therapeutically, most dialysis patients have to take phosphate binders. Here, we investigated effects of the Fe(3+)-based phosphate binder sucroferric...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelbary, Mohamed M. H., Kuppe, Christoph, Michael, Sareh Said-Yekta, Krüger, Thilo, Floege, Jürgen, Conrads, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187715/
https://www.ncbi.nlm.nih.gov/pubmed/35689007
http://dx.doi.org/10.1038/s41598-022-13552-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187715/
https://www.ncbi.nlm.nih.gov/pubmed/35689007
http://dx.doi.org/10.1038/s41598-022-13552-z

Ejemplares similares